Thyroid Eye Disease TED Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)
Thyroid Eye Disease (TED) Market is segmented By Drug Type (Biologics, Small Molecules, Others), By Treatment Type (Monotherapy, Combination Therapy), By Route of Administration (Oral, Intravenous, Subcutaneous), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD billion) for the above-mentioned segments.
Competitive overview of Thyroid Eye Disease TED Market
The major players operating in the Thyroid Eye Disease (TED) Market include Horizon Therapeutics, Immunovant, Viridian Therapeutics, Novartis, Apitope, IONIS Pharmaceuticals, Sobi (Swedish Orphan Biovitrum), River Vision Development Corp. and Diurnal Group Plc.
Thyroid Eye Disease TED Market Leaders
- Horizon Therapeutics
- Immunovant
- Viridian Therapeutics
- Novartis
- Apitope
*Disclaimer: Major players are listed in no particular order.
Thyroid Eye Disease TED Market - Competitive Rivalry, 2023
Thyroid Eye Disease TED Market
Market Consolidated
(Dominated by major players)
(Dominated by major players)
Market Fragmented
(Highly competitive with lots of players.)
(Highly competitive with lots of players.)
*Source: Coherent Market Insights